| Customization: | Available |
|---|---|
| Certification: | BRC, ISO, HACCP |
| Assay Method: | HPLC-MS, UV |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
The main indications of Citicoline are acute traumatic brain injury and brain consciousness after the operation. Moreover, citicoline can treat central nervous system dysfunction and unconsciousness caused by acute injury, paralysis agitans, tinnitus and nerve deafness, and poisoning caused by sleeping pills. In recent years, Citicoline is widely used in clinical for treatment of ischemic stroke, cerebral arteriosclerosis, multiinfarct dementia, Alzheimer's disease, and children viral encephalitis.
| Product name: Citicoline |
| Other names: CDP-choline |
| CAS NO.: 987-78-0 |
| M.F.: C14H26N4O11P2 |
| M.W.: 488.324 |
| Melting point: N/A |
| Boiling point: 851.4ºC at 760 mmHg |
){kind=link}